CRISPR/Cas9 gene editing: a new approach for overcoming drug resistance in cancer

The CRISPR/Cas9 system is an RNA-based adaptive immune system in bacteria and archaea. Various studies have shown that it is possible to target a wide range of human genes and treat some human diseases, including cancers, by the CRISPR/Cas9 system. In fact, CRISPR/Cas9 gene editing is one of the mos...

Descripción completa

Detalles Bibliográficos
Autores principales: Vaghari-Tabari, Mostafa, Hassanpour, Parisa, Sadeghsoltani, Fatemeh, Malakoti, Faezeh, Alemi, Forough, Qujeq, Durdi, Asemi, Zatollah, Yousefi, Bahman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204876/
https://www.ncbi.nlm.nih.gov/pubmed/35715750
http://dx.doi.org/10.1186/s11658-022-00348-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9204876/
https://www.ncbi.nlm.nih.gov/pubmed/35715750
http://dx.doi.org/10.1186/s11658-022-00348-2

Ejemplares similares